Bladder <scp>EpiCheck</scp> clinical utility to predict <scp>BCG</scp> response in non‐muscle‐invasive bladder cancer
The BE post-BCG status and variations in EpiScore values can help us identify patients at higher risk of any bladder cancer event and BCG failure promptly. These data can have an impact on disease management.
Authors
- María J. Ribal (ORCID: https://orcid.org/0000-0001-8142-5382)
- Josep L. Carrasco (ORCID: https://orcid.org/0000-0003-1184-0753)
- Bernat Padullés (ORCID: https://orcid.org/0009-0002-6177-3739)
- A. Franco (ORCID: https://orcid.org/0009-0004-6967-1862)
- Lourdes Mengual (ORCID: https://orcid.org/0000-0001-7418-9422)
- M. Durán (ORCID: https://orcid.org/0009-0007-6224-3971)
- Fiorella L. Roldán (ORCID: https://orcid.org/0000-0002-9152-922X)
- Mercedes Ingelmo‐Torres (ORCID: https://orcid.org/0000-0002-7116-2045)
- Laura Izquierdo (ORCID: https://orcid.org/0000-0001-6015-2987)
- Antonio Alcaraz (ORCID: https://orcid.org/0000-0003-2612-5250)
- Clàudia Mercader (ORCID: https://orcid.org/0000-0002-5710-958X)
- Marcel Figueras (ORCID: https://orcid.org/0000-0001-5846-7277)
Institutions
- Departament de Salut (ES)
- Hospital Clínic de Barcelona (ES)
- Fundació Clínic per a la Recerca Biomèdica (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1111/bju.16697
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01